Menu Back toSession-1006-Generic-Drug-Forum-II-Product-Development-for-Quality-Consistency

The 7th DIA China Annual Meeting


Session 1006 Generic Drug Forum - II - Product Development for Quality Consistency

Session Chair(s)

Yi  REN, PhD, MBA

Yi REN, PhD, MBA

  • General Manager
  • Nanjing Medichem Bio-Pharmaceutical Development Co. , China
Jane Y. Cai, PhD

Jane Y. Cai, PhD

  • Former Managing Director
  • DIA China, China

Generic reevaluation DIA meeting (EN&CN)

Speaker(s)

Xinsheng  Sun

Generic reevaluation DIA meeting (EN&CN)

Xinsheng Sun

  • Director
  • China Quality Association for Pharmaceuticals(CQAP), China
Bing V. Li

1006-2_BingLi_Scientific and Regulatory Considerations for Establishing Bioequivalence of Generic Drug Products in USA (EN&CN).pdf

Bing V. Li

  • Pharmacologist
  • FDA, United States
Chao  Ye, PhD

Considerations for OTC Development For Emerging Markets (EN&CN)

Chao Ye, PhD

  • Associate Director, Research and Development, OTC
  • Johnson & Johnson China, China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650